Virtual Rehabilitation in Parkinson Disease A Dopamine Transporter Imaging Study

被引:5
|
作者
Toldo, Juliana M. P. [1 ]
Arjona, Michelly [1 ]
Campos Neto, Guilherme C. [1 ]
Vitor, Taise [1 ]
Nogueira, Solange Amorim [1 ]
Amaro, Edson, Jr. [1 ]
Saba, Roberta A. [2 ,3 ]
Silva, Sonia M. C. A. [2 ,3 ]
Ferraz, Henrique B. [3 ]
Felicio, Andre C. [1 ]
机构
[1] Hosp Israelita Albert Einstein, Sao Paulo, Brazil
[2] Inst Assistencia Med Servidor Publ Estadual Sao P, Sao Paulo, Brazil
[3] Univ Fed Sao Paulo, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Parkinson Disease; Virtual Rehabilitation; Dopamine Transporter; SPECT; TC-99M-TRODAT-1; SPECT; STRIATAL DOPAMINE; BALANCE; MOTOR; EXERCISE; ATTENTION; DEFICITS; REALITY; GAIT;
D O I
10.1097/PHM.0000000000001574
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective The aim of the study was to verify the effect of a virtual rehabilitation protocol for patients with Parkinson disease, primarily assessing striatal dopamine transporters and secondarily motor symptoms and quality of life. Design Nineteen patients with Parkinson disease underwent an 8-wk virtual rehabilitation protocol using XBOX 360S. Evaluation of dopamine transporters was performed by single-photon emission computed tomography using TRODAT-1 as the radioligand. Participants were clinically assessed using the Unified Parkinson Disease Rating Scale to quantify motor symptoms. Moreover, the Parkinson Disease Questionnaire and Short-Form Health Status Survey were used to assess quality of life and the Berg Balance Scale to assess balance. Results Regarding our primary outcome, dopamine transporter was significantly increased in the putamen contralateral to the clinically most affected body side (P = 0.034) considering preintervention and postintervention measurements. Furthermore, we observed significant improvement in Unified Parkinson Disease Rating Scale (10-point reduction, P = 0.001), Parkinson Disease Questionnaire (11.3-point reduction, P = 0.001), Short-Form Health Status Survey ("Functional capacity," P = 0.001; "Pain," P = 0.006; and "Mental Health" domains, P < 0.001), and Berg Balance Scale (5-point increase, P = 0.015). Conclusions In our group of Parkinson disease patients, this virtual rehabilitation protocol enabled a dopamine transporter increase in the region of the putamen contralateral to the clinically most affected body side. Moreover, motor signs and quality of life were significantly improved.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 50 条
  • [21] Dopamine transporter imaging to predict the risk of aspiration in patients with Parkinson's disease
    Tanimura, Jun
    Yamamoto, Toshiyuki
    Shigemoto, Yoko
    Sato, Noriko
    Takahashi, Yuji
    PARKINSONISM & RELATED DISORDERS, 2025, 132
  • [22] Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease
    Smith, Kara M.
    Xie, Sharon X.
    Weintraub, Daniel
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (08): : 864 - 870
  • [23] PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease
    Ilgin, N
    Zubieta, J
    Reich, SG
    Dannals, RF
    Ravert, HT
    Frost, JJ
    NEUROLOGY, 1999, 52 (06) : 1221 - 1226
  • [24] Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease
    Saari, Laura
    Kivinen, Katri
    Gardberg, Maria
    Joutsa, Juho
    Noponen, Tommi
    Kaasinen, Valtteri
    NEUROLOGY, 2017, 88 (15) : 1461 - 1467
  • [25] Dopamine transporter imaging in very long-standing Parkinson's disease
    Djaldeni, R.
    Lorberboym, M.
    Karmon, Y.
    Hellmann, M.
    Melamed, E.
    MOVEMENT DISORDERS, 2009, 24 : S261 - S262
  • [26] Dopamine Transporter Imaging Predicts Long Term Outcomes in Parkinson's Disease
    Ravina, Bernard M.
    Marek, Kenneth
    Eberly, Shirley
    Oakes, David
    Shoulson, Ira
    ANNALS OF NEUROLOGY, 2011, 70 : S81 - S81
  • [27] Extradural motor cortex stimulation and dopamine transporter imaging in advanced Parkinson's disease: a pilot study
    Di Giuda, D.
    Bruno, I.
    Cioni, B.
    Bentivoglio, A. R.
    Dambra, D. P.
    Mazza, R.
    Cocciolillo, F.
    Giordano, A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 : S285 - S285
  • [28] Smell tests compared to dopamine transporter imaging in diagnosis of idiopathic Parkinson's disease: A pilot study
    Deeb, J
    Findley, LJ
    Shah, M
    Muhammed, N
    Hawkes, CH
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (01): : 128 - 128
  • [29] The dopamine transporter: Importance in Parkinson's disease
    Nutt, JG
    Carter, JH
    Sexton, GJ
    ANNALS OF NEUROLOGY, 2004, 55 (06) : 766 - 773
  • [30] Magnetic resonance and dopamine transporter imaging for the diagnosis of Parkinson's disease: a narrative review
    Vicentini Otani, Rafael Tomio
    Silvestre Yamamoto, Joyce Yuri
    Nunes, Douglas Mendes
    Haddad, Monica Santoro
    Parmera, Jacy Bezerra
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2022, 80 (05) : 116 - 125